Quantcast
Last updated on April 18, 2014 at 9:36 EDT

Latest Mitral valve Stories

2013-10-24 08:34:20

Neovasc's Tiara(TM) Program for the Transcatheter Treatment of Mitral Valve Disease Will Be Featured in Two Sessions VANCOUVER, Oct. 24, 2013 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that researchers will present data on the company's Tiara(TM) transcatheter mitral valve in preclinical development for the treatment of mitral valve disease at the upcoming 25(th) Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the...

2013-10-10 08:29:04

Competitors Seeking To Replicate Success of Edwards Lifesciences' SAPIEN Valve, According to Millennium Research Group TORONTO, Oct. 10, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States market for heart valve devices will experience strong growth, driven primarily by the rapid adoption of transcatheter heart valve devices. These premium-priced devices represent new technologies that...

2013-10-01 17:56:33

Mayo Clinic study examines costs following operating room and recovery improvement efforts The total hospital cost of mitral valve repair surgery — from the time a patient is admitted to the hospital until release — is similar, whether performed through small port incisions using robotic equipment or via the conventional open-chest method, a Mayo Clinic study of 370 patients found. Importantly, robotic surgeries were just as safe as conventional open procedures, but patients who...

2013-09-05 08:28:48

Millennium Research Group's New Market Share Data Clarifies the Competitive Situation of the Chinese Heart Valve Market TORONTO, Sept. 5, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Chinese heart valve market is underpenetrated and will grow rapidly in the next decade. But this particular market differs in significant ways from mature markets, and the differences need to be taken into account...

2013-08-14 12:22:08

In a study that included patients with mitral valve regurgitation due to a condition known as flail mitral valve leaflets, performance of early surgical correction compared with initial medical management was associated with greater long-term survival and lower risk of heart failure, according to a study in the August 14 issue of JAMA. "Degenerative mitral regurgitation [backflow of blood from the left ventricle to the left atrium due to mitral valve insufficiency] is common and can be...

2013-08-14 11:56:21

Mayo Clinic-led international study challenges long-held belief Patients with severe mitral valve regurgitation who are otherwise healthy should have mitral valve repair surgery sooner rather than later, even if they feel no symptoms, a Mayo Clinic-led study by U.S. and European researchers found. The results challenge the long-held belief that it is safer to "watch and wait" until a patient has symptoms, such as shortness of breath. This is the largest study to show that patients who...

2013-07-01 16:26:03

Scripps Clinic only trial site in San Diego to offer MitraClip device SAN DIEGO, July 1, 2013 /PRNewswire/ -- Virginia Anderer, a native of Chicago, never thought she would see her beloved city again due to her failing heart which prevented her from traveling. But the 84-year-old Southern California resident was recently able to return to the Windy City - with her doctor's blessing - thanks in part to a minimally invasive device that has the potential to fix her leaky heart valve....

2013-07-01 08:26:50

TEL AVIV, Israel, July 1, 2013 /PRNewswire/ -- MitrAssist, [http://www.mitrassist.com ] a portfolio company of The Trendlines Group [C:\\Documents and Settings\\User\\%D7%A9%D7%95%D7%9C%D7%97%D7%9F %D7%94%D7%A2%D7%91%D7%95%D7%93%D7%94\\%D7%90%D7%A4%D7%A8%D7%AA\\Trendlines Group%E2%80%99s ]'s Misgav Venture Accelerator [http://www.misgav-venture.com ], recently completed a raise of $1 million from angel investors and a multinational private strategic investor. The company set...

2013-06-26 12:31:47

PALO ALTO, California and MUNICH, June 26, 2013 /PRNewswire/ -- Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised $8.5M in a Series A financing. The round was co-led by healthcare investment specialists Wellington Partners and Seventure Partners, along with seed investor High-Tech Gruenderfonds Management GmbH (HTGF). The proceeds will provide capital for further...

2013-06-08 23:03:29

HeartStitch today announced that after testing more than 50 Transapical closures in porcine and bovine beating hearts the final iteration of the device was successfully tested at the Texas Heart Institute. Fountain Valley, California (PRWEB) June 08, 2013 Dr. William Cohn and Prof. Dr. Anthony Nobles completed testing of the HeartStitch TA Transapical access and closure. Dr´s Cohn and Nobles performed the procedure using the latest generation of the HeartStitch TA. The procedure allows...